Ratnesh K Singh

US Patent:

20130297802, Nov 7, 2013

Filed:

May 3, 2013

Appl. No.:

13/887001

Inventors:

Josephine Suganthi - Santa Clara CA, US
Ratnesh Singh - Santa Clara CA, US
Ravia Kondamuru - Santa Clara CA, US

Assignee:

Citrix Systems, Inc. - Fort Lauderdale FL

International Classification:

H04L 12/70

US Classification:

709226

Abstract:

The present application is directed towards systems and methods for adaptive application provisioning for cloud services. An appliance deployed in a network as a gateway may be able to transparently monitor application activity in a cloud computing environment provided by one or more servers, including servers executed by virtual machines, bare-metal or non-virtual servers, or other computing devices. In some embodiments, the appliance may monitor one or more network metrics, including bandwidth usage, latency, congestion, or other issues; and/or may monitor application health or server or virtual machine statistics, including memory and processor usage, bandwidth usage, latency, or other metrics. Responsive to one or more metrics exceeding a threshold, the appliance may automatically provision or start, or deprovision or shut down, one or more virtual or physical machines from a cloud service provider, and may provide configuration information to the provisioned or started machines as needed.

US Patent:

20210155895, May 27, 2021

Filed:

Apr 4, 2017

Appl. No.:

16/090871

Inventors:

- CARLSBAD CA, US
Ratnesh Singh - Dublin CA, US
Michael D. West - Mill Valley CA, US
Hal Sterberg - Berkeley CA, US
David LAROCCA - Alameda CA, US

Assignee:

LINEAGE CELL THERAPEUTICS, INC. - CARLSBAD CA

International Classification:

C12N 5/00
C12N 5/079

Abstract:

Pluripotent stem cell-derived 3D retinal organoid compositions and methods of making using the same are disclosed.

US Patent:

20200368394, Nov 26, 2020

Filed:

Jul 31, 2018

Appl. No.:

16/635473

Inventors:

- Alameda CA, US
Ratnesh SINGH - San Ramon CA, US
Oscar CUZZANI - Walnut Creek CA, US
Michael ONORATO - San Francisco CA, US
Francois BINETTE - Napa CA, US

Assignee:

Lineage Therapeutics, Inc. - Carlsbad CA

International Classification:

A61L 27/36
A61K 35/545
A61K 31/137
A61F 2/14
A61L 27/54

Abstract:

Bioprosthetic retinal grafts (or devices) comprising stem cell derived tissues and/or cells may be used to slow the progression of retinal degenerative disease, slow the progression of retinal degenerative disease after traumatic injury, slow the progression of age related macular degeneration (AMD), prevent retinal degenerative disease, prevent retinal degenerative disease after traumatic injury, prevent AMD, restore retinal pigment epithelium (RPE), photoreceptor cells (PRCs) and retinal ganglion cells (RGCs) lost from disease, injury or genetic abnormalities, increasing RPE, PRCs and RCGs, treat RPE, PRCs and RCG defects in a subject, or for other purposes. Bioprosthetic retinal grafts may comprise a bioprosthetic carrier or scaffold suitable for implantation into the ocular space of a subject's eye, to form a bioprosthetic retinal patch. In certain embodiments, the bioprosthetic retinal patch may comprise multiple pieces of stem cell derived tissues or cells on a carrier or scaffold, which may be used to treat large areas of retinal degeneration or damage, or for other purposes.